Johnson & Johnson announces Phase 3 ASTRO study met primary endpoints
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
Johnson & Johnson Goes to Trial on Third Talc Bankruptcy Plan
Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to resolve one of the largest mass tort lawsuits through an affiliate it placed into ...